Omega-3 (EPA/DHA) — Mechanism, Benefits, Dosing

Overview

Long-chain polyunsaturated fatty acids (EPA and DHA) found in fatty fish and algae. Incorporated into cell membranes and serve as precursors to anti-inflammatory eicosanoids.

Natural sources

Salmon
Mackerel
Sardines
Anchovies
Algae (vegan source)

Common forms

Triglyceride form (best absorbed)
Ethyl ester (cheaper)
rTG re-esterified TG (premium)
Phospholipid (krill)

Forms & variants of Omega-3 (EPA/DHA)

Different chemical forms of Omega-3 (EPA/DHA) behave differently. Browse each form's mechanism, bioavailability, and best-use context.

EPA-only (Vascepa)

EPA-Only Omega-3

Pure EPA reduces residual cardiovascular risk on statins.

Prenatal DHA

DHA (Prenatal)

Critical fatty acid for fetal brain and retinal development.

Mechanism of action

EPA/DHA replace arachidonic acid in cell membranes, shifting eicosanoid production from pro-inflammatory (PGE2) to resolution mediators (resolvins, protectins).

Pathways

· Eicosanoid production (COX/LOX)
· Specialized pro-resolving mediators (SPMs)
· Membrane fluidity

Enzymes

· COX-2 (↓)
· 5-LOX (modulates)

Effects on the body

Decreases

Triglycerides (~20–30%)

Decreases

Systemic inflammation (hs-CRP)

Supports

Membrane health & cognition

Decreases

Resting heart rate

Organ system effects

Cardiovascular

Lowers TG, modestly lowers BP and resting HR, may reduce major cardiovascular events at 4 g/day EPA.

Brain & CNS

DHA is ~30% of brain phospholipids; supports synaptic membranes.

Eye

DHA concentrated in retinal photoreceptors.

Evidence-based benefits

Reduces triglycerides

Strong evidence

Reduces major cardiovascular events at high-dose prescription EPA

Strong evidence

Reduces depression severity (especially EPA-dominant)

Moderate evidence

Reduces joint pain in rheumatoid arthritis

Moderate evidence

Potential side effects

Common

· Fishy burps
· Mild GI upset

Rare

· Increased bleeding time at very high doses

Serious

· Atrial fibrillation risk at 4 g/day in some trials

Drug interactions

Anticoagulants (warfarin, DOACs)

May increase bleeding risk at high doses.

moderate

Anti-hypertensives

Additive BP lowering.

minor

Supplement interactions

Pairs well with

Vitamin E
Protects PUFAs from peroxidation.
Vitamin D3
Synergistic for cardiovascular and immune health.

Avoid combining with

High-dose vitamin E + other antioxidants
May blunt some adaptive responses to training.

Dosing & bioavailability

Typical dose

2–3 g combined EPA+DHA

Beginner dose

1 g combined EPA+DHA

Study range

1–4 g/day

Upper safe limit

FDA: 3 g/day from supplements (5 g total)

Best form

rTG (re-esterified triglyceride) form, third-party tested for oxidation

Timing

With largest fatty meal

With food?

With food containing fat — critical for absorption

Where to buy

Affiliate-style search links to reputable retailers. We don't endorse specific brands — verify third-party testing (USP, NSF, Informed Sport) before purchase.

Fatty Acid

Omega-3 (EPA…

Amazon

Wide selection · fast shipping

Fatty Acid

Omega-3 (EPA…

iHerb

Global delivery · curated brands

Fatty Acid

Omega-3 (EPA…

Thorne

Practitioner-grade · NSF tested

Scientific evidence (11)

RCTNEJM · 2019

Marine n-3 fatty acids and prevention of cardiovascular disease (REDUCE-IT)

Bhatt DL, et al.

8,179 statin-treated patients with elevated TG, 4 g/day icosapent ethyl vs placebo × 4.9 yr.

Key findings

25% reduction in major adverse cardiovascular events (HR 0.75).

Open study

Systematic reviewPubMed (NLM) · 1970

PubMed: Omega-3 (EPA/DHA) — Reduces triglycerides

Live PubMed search

Live results for "Omega-3 (EPA/DHA) Reduces triglycerides" across the PubMed/MEDLINE peer-reviewed index.

Key findings

Opens current human and preclinical literature matching Omega-3 (EPA/DHA) and "Reduces triglycerides". Filter by RCT, meta-analysis, or year on the results page.

Open study

Systematic reviewPubMed (NLM) · 1970

PubMed: Omega-3 (EPA/DHA) — Reduces major cardiovascular events at high-dose prescription EPA

Live PubMed search

Live results for "Omega-3 (EPA/DHA) Reduces major cardiovascular events at high-dose prescription EPA" across the PubMed/MEDLINE peer-reviewed index.

Key findings

Opens current human and preclinical literature matching Omega-3 (EPA/DHA) and "Reduces major cardiovascular events at high-dose prescription EPA". Filter by RCT, meta-analysis, or year on the results page.

Open study

Systematic reviewPubMed (NLM) · 1970

PubMed: Omega-3 (EPA/DHA) — Reduces depression severity

Live PubMed search

Live results for "Omega-3 (EPA/DHA) Reduces depression severity" across the PubMed/MEDLINE peer-reviewed index.

Key findings

Opens current human and preclinical literature matching Omega-3 (EPA/DHA) and "Reduces depression severity". Filter by RCT, meta-analysis, or year on the results page.

Open study

Systematic reviewPubMed (NLM) · 1970

PubMed: Omega-3 (EPA/DHA) — Reduces joint pain in rheumatoid arthritis

Live PubMed search

Live results for "Omega-3 (EPA/DHA) Reduces joint pain in rheumatoid arthritis" across the PubMed/MEDLINE peer-reviewed index.

Key findings

Opens current human and preclinical literature matching Omega-3 (EPA/DHA) and "Reduces joint pain in rheumatoid arthritis". Filter by RCT, meta-analysis, or year on the results page.

Open study

Systematic reviewPubMed (NLM) · 1970

PubMed: Omega-3 (EPA/DHA) — randomized controlled trial

Live PubMed search

Live results for "Omega-3 (EPA/DHA) randomized controlled trial" across the PubMed/MEDLINE peer-reviewed index.

Key findings

Opens current human and preclinical literature matching Omega-3 (EPA/DHA) and "randomized controlled trial". Filter by RCT, meta-analysis, or year on the results page.

Open study

Systematic reviewPubMed (NLM) · 1970

PubMed: Omega-3 (EPA/DHA) — meta-analysis

Live PubMed search

Live results for "Omega-3 (EPA/DHA) meta-analysis" across the PubMed/MEDLINE peer-reviewed index.

Key findings

Opens current human and preclinical literature matching Omega-3 (EPA/DHA) and "meta-analysis". Filter by RCT, meta-analysis, or year on the results page.

Open study

Systematic reviewPubMed (NLM) · 1970

PubMed: Omega-3 (EPA/DHA) — pharmacokinetics

Live PubMed search

Live results for "Omega-3 (EPA/DHA) pharmacokinetics" across the PubMed/MEDLINE peer-reviewed index.

Key findings

Opens current human and preclinical literature matching Omega-3 (EPA/DHA) and "pharmacokinetics". Filter by RCT, meta-analysis, or year on the results page.

Open study

Systematic reviewPubMed (NLM) · 1970

PubMed: Omega-3 (EPA/DHA) — safety adverse events

Live PubMed search

Live results for "Omega-3 (EPA/DHA) safety adverse events" across the PubMed/MEDLINE peer-reviewed index.

Key findings

Opens current human and preclinical literature matching Omega-3 (EPA/DHA) and "safety adverse events". Filter by RCT, meta-analysis, or year on the results page.

Open study

Systematic reviewPubMed (NLM) · 1970

PubMed: Omega-3 (EPA/DHA) — dose response

Live PubMed search

Live results for "Omega-3 (EPA/DHA) dose response" across the PubMed/MEDLINE peer-reviewed index.

Key findings

Opens current human and preclinical literature matching Omega-3 (EPA/DHA) and "dose response". Filter by RCT, meta-analysis, or year on the results page.

Open study

Systematic reviewGoogle Scholar · 1970

Google Scholar: Omega-3 (EPA/DHA) — clinical evidence

Live Scholar search

Cross-database citation index for Omega-3 (EPA/DHA) as it relates to "clinical evidence".

Key findings

Includes preprints, theses, and journal articles. Useful for tracking citation counts and follow-on work.

Open study

Educational use only. This profile is not medical advice. Consult a qualified healthcare professional before starting any supplement, especially if you take prescription medication or have a chronic condition.